Meinian Onehealth
Health 100 provides medical examinations and services.
Meinian Onehealth, founded in January, 2004 and headquartered in Shanghai, is a health checkup and medical service provider. The founder is Yu Rong. Listed on the SZSE on May 18, 2005, the company's major shareholders are Alibaba (China) Network Technology Co., Ltd., Shanghai Days Billion Asset Management Co., Ltd. and Beijing Shijichanghe Technology Group Co., Ltd.. Rivals that have direct and indirect competition with Meinian Onehealth include iKang Guobin, JD Health, Babyscripts, Conversa, etc.
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Jan 30, 2023 02:13 PM
East China medicine "liraglutide" goes to sea
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Yanye new crown drug 3CL protein inhibitor has been suspended approval
SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year
EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.
Jun 06, 2024 06:18 PM
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
Meinian health semi annual report: the net loss in the first half of the year was 428 million yuan, and the loss narrowed
Aikang Guobin reports two securities analysts of Guoxin Securities to China Securities Regulatory Commission